Case Study

Aventis (B): One year after the merger

5 pages
December 2002
Reference: IMD-3-1106

In December 1999, one year after the merger of Hoechst and Rhône-Poulenc, the new company Aventis had increased its revenues, operating margins and reduced costs. It was also well-positioned to achieve some of its major strategic goals. In November 2000, Aventis announced its decision to sell of its crop sciences operations. In this way, Aventis became a focussed pharmaceuticals company.

Keywords
Mergers and Acquisitions, Pharmaceuticals, Integration
Settings
World/global
December 1999
Type
Published Sources
Copyright
© 2002
Available Languages
English
Case clearing houses
Contact

Research Information & Knowledge Hub for additional information on IMD publications

Discover our latest research
IMD's faculty and research teams publish articles, case studies, books and reports on a wide range of topics